Patent · US Active

Nano-scale contrast agents and methods of use

US8911708B2 · kind B2 · utility

5Cited by
23References
18Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 17, 2012
Grant dateDec 16, 2014
Priority date
Expiry dateDec 17, 2032

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K49/0438
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Compositions and methods are disclosed for evaluating a subject's vasculature integrity, for differentiating between a malignant lesion and a benign lesion, for evaluating the accessibility of a tumor to nano-sized therapeutics, for treating tumors, and for live or real time monitoring of a nano-probe's biodistribution.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.